Valuing Diagnostic Innovations: Towards Responsible Health Technology Assessment

Ellen Moors*, A. Peine

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review


Diagnostic innovation is increasingly perceived as an institutional interplay with many heterogeneous stakeholders in which users are more proactively involved in diagnosis. This challenges traditional Health Technology Assessment (HTA) practices, focusing on efficacy, safety, quality, and costs. Other values become important in diagnostic innovations, including social and ethical norms, expectations, positions, and distributed roles of stakeholders. This chapter asks which set of values, which logic of valuing could be leading in such new practices of HTA for diagnostic innovations. It zooms in on the current logic of valuing in HTA. It presents various empirical cases reporting on diagnostic innovations, and reflects on how HTA strategies, policies, and interventions for practitioners and users of diagnostic innovations could be more flexible and responsible.
Original languageEnglish
Title of host publicationEmerging Technologies for Diagnosing Alzheimer’s Disease
EditorsMarianne Boennink, Harro van Lente, Ellen Moors
Number of pages17
ISBN (Electronic)978-1-137-54097-3
ISBN (Print)978-1-137-54096-6
Publication statusPublished - 2016
Externally publishedYes

Publication series

SeriesHealth, Technology and Society


Dive into the research topics of 'Valuing Diagnostic Innovations: Towards Responsible Health Technology Assessment'. Together they form a unique fingerprint.

Cite this